VIOLIN Logo
Cov19VaxKB Banner
Search: for Help
Home
Introduction
Statistics
Authorized Vaccines
Phase III Vaccines
Phase II Vaccines
Phase I Vaccines
Preclinical Vaccines
Vaccine Safety
Vaccine Design
Literature Search
News
Data Submission
Data Exchange
Data Download
Tutorial
Links
Documentation
Updates
Acknowledgements
FAQs
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From May 01, 2024 To May 02, 2024:


SARS-CoV-2 (COVID-19)

  1. Almansour I, Jermy BR. Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV Human vaccines & immunotherapeutics 20(1):2346390 2024 [PMID: 38691025]
  2. Lan X, Chen G, Zhou R, Zheng K, Cai S, Wei F, Jin Z, Mao X. An SEIHR model with age group and social contact for analysis of Fuzhou COVID-19 large wave Infectious Disease Modelling 9(3):728-743 2024 [PMID: 38689855]
  3. Luo L, Risk M, Shi X. Online causal inference with application to near real-time post-market vaccine safety surveillance Statistics in medicine 2024 [PMID: 38693559]
  4. Zemni I, Gara A, Bennasrallah C, Ezzar S, Kacem M, Chokri R, Maatouk A, Abroug H, Dhouib W, Fredj MB, Bouanene I, Belguith AS. Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study BMC infectious diseases 24(1):461 2024 [PMID: 38693500]
  5. Zink N. Möglichst guter Impfschutz bei Immunsupprimierten besonders wichtig MMW Fortschritte der Medizin 166(8):20 2024 [PMID: 38693371]
  6. Callaway E. Scientists tried to give people COVID - and failed Nature 2024 [PMID: 38693229]
  7. Mastroleo I. Use of experimental vaccines is ethically permissible during public health emergencies Vaccine 2024 [PMID: 38692954]
  8. Cha-Silva AS, Gavaghan MB, Bergroth T, Alexander-Parrish R, Yang J, Draica F, Patel J, Garner DA, Stanford RH, Meier G, McLaughlin JM, Nguyen JL. Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review American journal of therapeutics 31(3):e246-e257 2024 [PMID: 38691664]
  9. Santi BM, Verhoef PA. COVID-19 Hospitalization in Hawai'i and Patterns of Insurance Coverage, Race and Ethnicity, and Vaccination JAMA network open 7(5):e243696 2024 [PMID: 38691362]
  10. Yamada Y, Ogawa Y, Shimizu S, Matsuoka Y, Yamamoto Y. Correction to: Longitudinal Association Between Social Isolation and COVID-19 Vaccine Uptake in Japanese Older Citizen: an Observational Study Journal of general internal medicine 2024 [PMID: 38691210]
  11. Gygi JP, Maguire C, Patel RK, Shinde P, Konstorum A, Shannon CP, Xu L, Hoch A, Jayavelu ND, Haddad EK, Reed EF, Kraft M, McComsey GA, Metcalf JP, Ozonoff A, Esserman D, Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen LB, van Bakel H, Wilson M, Eckalbar WL, Maecker HT, Langelier CR, Steen H, Altman MC, Montgomery RR, Levy O, Melamed E, Pulendran B, Diray-Arce J, Smolen KK, Fragiadakis GK, Becker PM, Sekaly RP, Ehrlich LI, Fourati S, Peters B, Kleinstein SH, Guan L. Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality The Journal of clinical investigation 134(9) 2024 [PMID: 38690733]
  12. Maisonneuve E, Favre G, Boucoiran I, Dashraath P, Panchaud A, Baud D. Post-COVID-19 condition: recommendations for pregnant individuals The Lancet regional health. Europe 40:100916 2024 [PMID: 38689607]
  13. Tate J, Crooks VA, Snyder J. "We were leery of going": qualitatively exploring Canadian international retirement migrants' travel-related decisions during the COVID-19 pandemic Tropical diseases, travel medicine and vaccines 10(1):9 2024 [PMID: 38689364]
  14. Suenaga M, Yamauchi S, Morikawa R, Noji R, Kano Y, Tokunaga M, Kinugasa Y. Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer In vivo (Athens, Greece) 38(3):1278-1284 2024 [PMID: 38688608]
  15. Pinto Pereira SM, Nugawela MD, Stephenson T, Foret-Bruno P, Dalrymple E, Xu L, Whittaker E, Heyman I, Ford T, Segal T, Chalder T, Ladhani SN, Mensah AA, McOwat K, Simmons R, Shafran R. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study Scientific reports 14(1):9957 2024 [PMID: 38693285]
  16. Han K, Lee B, Lee D, Heo G, Oh J, Lee S, Apio C, Park T. Forecasting the spread of COVID-19 based on policy, vaccination, and Omicron data Scientific reports 14(1):9962 2024 [PMID: 38693172]
  17. Ding Y, Johar GV, Morris MW. When the one true faith trumps all: Low religious diversity, religious intolerance, and science denial PNAS nexus 3(4):pgae144 2024 [PMID: 38689708]
  18. Slavec A, Iwanowska M, Bałandynowicz-Panfil K, Olah Ș, Zvonar MŠ, Štebe J, Łosiewicz M. Determinants of COVID-19 vaccination intention in Central and Eastern Europe: A cross-sectional study in Poland, Romania, and Slovenia Archives of public health = Archives belges de sante publique 82(1):60 2024 [PMID: 38689314]
  19. Zhong Y, Kang AYH, Tay CJX, Li HE, Elyana N, Tan CW, Yap WC, Lim JME, Le Bert N, Chan KR, Ong EZ, Low JG, Shek LP, Tham EH, Ooi EE. Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children Nature medicine 2024 [PMID: 38689059]
  20. Yimer SA, Booij BB, Tobert G, Hebbeler A, Oloo P, Brangel P, L'Azou Jackson M, Jarman R, Craig D, Avumegah MS, Mandi H, Endy T, Wooden S, Clark C, Bernasconi V, Shurtleff A, Kristiansen PA. Rapid diagnostic test: a critical need for outbreak preparedness and response for high priority pathogens BMJ global health 9(4) 2024 [PMID: 38688565]
  21. Taylor A, Neutze J, Moreland NJ, Webb R. Reduction in Acute Post-Streptococcal Glomerulonephritis Incidence in Counties Manukau, New Zealand, after the COVID-19 Pandemic The American journal of tropical medicine and hygiene 2024 [PMID: 38688264]
  22. Nakajima I, Fukuda K, Sumi T, Yamashiro K. Exaggerated Immune Response to Fungal Keratitis Post-COVID-19 Vaccination Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) :100063 2024 [PMID: 38692509]
  23. Fleary SA, Shahn Z, Teasdale CA. Effects of parental childhood cultural health environment on children's influenza and COVID-19 vaccination status Vaccine 2024 [PMID: 38688805]
  24. Niessen FA, Bruijning-Verhagen PCJL, Bonten MJM, Knol MJ. Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study Vaccine 2024 [PMID: 38688804]
  25. Shrestha A, Basnet S, Kc S. Subclinical hepatitis E virus genotype 1 infection: The concept of "dynamic human reservoir" World journal of hepatology 16(4):506-510 2024 [PMID: 38689746]
  26. Mazunina EP, Gushchin VA, Kleymenov DA, Siniavin AE, Burtseva EI, Shmarov MM, Mukasheva EA, Bykonia EN, Kozlova SR, Evgrafova EA, Zolotar AN, Shidlovskaya EV, Kirillova ES, Krepkaia AS, Usachev EV, Kuznetsova NA, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response Frontiers in immunology 15:1381508 2024 [PMID: 38690272]
  27. Every-Palmer S, Hansby O, Barry-Walsh J. Stalking, harassment, gendered abuse, and violence towards politicians in the COVID-19 pandemic and recovery era Frontiers in psychiatry 15:1357907 2024 [PMID: 38690205]
  28. Weeks WB. Storytelling in Scientific Conferences: Mitigating Misinformation Risk International journal of public health 69:1607289 2024 [PMID: 38689667]
  29. Albrecht S, Grässli F, Cusini A, Brucher A, Goppel S, Betschon E, Möller JC, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, Risch L, Von Kietzell M, Schlegel M, Vernazza P, Kuster SP, Kahlert CR, Kohler P. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study Swiss medical weekly 154:3734 2024 [PMID: 38689545]
  30. Kim M, Choi Y, Kim SY, Cho A, Kim H, Chae JH, Kim KJ, Park D, Kwon YS, Kim MJ, Yum MS, Kong JH, Lee YJ, Lim BC. Severe Neurological Manifestation Associated With Coronavirus Disease 2019 in Children During the Omicron Variant-Predominant Period Pediatric neurology 156:17-25 2024 [PMID: 38692086]
  31. Takahashi H, Eguchi J, Watanabe M, Nakayama M, Wada J. Reduced Immunogenicity of COVID-19 Vaccine in Obese Patients with Type 2 Diabetes: A Cross-Sectional Study Acta medica Okayama 78(2):185-191 2024 [PMID: 38688836]
  32. Amir-Kabirian B, Annie FH, Koontz M, Ihle R. Sinus Tachycardia Following COVID-19 and Its Implications Cureus 16(3):e57320 2024 [PMID: 38690504]
  33. Choi HK, Maity M, Qureshi M, Haider A, Kapadia S, Fuerte S, Antony S, Razzaq W, Akbar A. Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes Cureus 16(3):e57288 2024 [PMID: 38690470]
  34. Suzuki R. [Mast Cell-Neutrophil Communication Regulates Allergic Diseases] Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 144(5):483-488 2024 [PMID: 38692921]
  35. Kleebaoon A, Mungmunpuntipantip R, Wiwanitkit V. Satisfaction and reasons for participation in a Covid-19 vaccine clinical trial The National medical journal of India 36(3):204-205 2023 [PMID: 38692618]

See more by clicking HERE

Coronavirus

  1. Almansour I, Jermy BR. Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV Human vaccines & immunotherapeutics 20(1):2346390 2024 [PMID: 38691025]
  2. Cha-Silva AS, Gavaghan MB, Bergroth T, Alexander-Parrish R, Yang J, Draica F, Patel J, Garner DA, Stanford RH, Meier G, McLaughlin JM, Nguyen JL. Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19-Related Hospitalization and Mortality: A Systematic Literature Review American journal of therapeutics 31(3):e246-e257 2024 [PMID: 38691664]
  3. Santi BM, Verhoef PA. COVID-19 Hospitalization in Hawai'i and Patterns of Insurance Coverage, Race and Ethnicity, and Vaccination JAMA network open 7(5):e243696 2024 [PMID: 38691362]
  4. Gygi JP, Maguire C, Patel RK, Shinde P, Konstorum A, Shannon CP, Xu L, Hoch A, Jayavelu ND, Haddad EK, Reed EF, Kraft M, McComsey GA, Metcalf JP, Ozonoff A, Esserman D, Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen LB, van Bakel H, Wilson M, Eckalbar WL, Maecker HT, Langelier CR, Steen H, Altman MC, Montgomery RR, Levy O, Melamed E, Pulendran B, Diray-Arce J, Smolen KK, Fragiadakis GK, Becker PM, Sekaly RP, Ehrlich LI, Fourati S, Peters B, Kleinstein SH, Guan L. Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality The Journal of clinical investigation 134(9) 2024 [PMID: 38690733]
  5. Suenaga M, Yamauchi S, Morikawa R, Noji R, Kano Y, Tokunaga M, Kinugasa Y. Chemotherapy and COVID-19 Vaccination in Patients With Gastrointestinal Cancer In vivo (Athens, Greece) 38(3):1278-1284 2024 [PMID: 38688608]
  6. Pinto Pereira SM, Nugawela MD, Stephenson T, Foret-Bruno P, Dalrymple E, Xu L, Whittaker E, Heyman I, Ford T, Segal T, Chalder T, Ladhani SN, Mensah AA, McOwat K, Simmons R, Shafran R. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study Scientific reports 14(1):9957 2024 [PMID: 38693285]
  7. Han K, Lee B, Lee D, Heo G, Oh J, Lee S, Apio C, Park T. Forecasting the spread of COVID-19 based on policy, vaccination, and Omicron data Scientific reports 14(1):9962 2024 [PMID: 38693172]
  8. Fleary SA, Shahn Z, Teasdale CA. Effects of parental childhood cultural health environment on children's influenza and COVID-19 vaccination status Vaccine 2024 [PMID: 38688805]
  9. Mazunina EP, Gushchin VA, Kleymenov DA, Siniavin AE, Burtseva EI, Shmarov MM, Mukasheva EA, Bykonia EN, Kozlova SR, Evgrafova EA, Zolotar AN, Shidlovskaya EV, Kirillova ES, Krepkaia AS, Usachev EV, Kuznetsova NA, Ivanov IA, Dmitriev SE, Ivanov RA, Logunov DY, Gintsburg AL. Trivalent mRNA vaccine-candidate against seasonal flu with cross-specific humoral immune response Frontiers in immunology 15:1381508 2024 [PMID: 38690272]
  10. Albrecht S, Grässli F, Cusini A, Brucher A, Goppel S, Betschon E, Möller JC, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, Risch L, Von Kietzell M, Schlegel M, Vernazza P, Kuster SP, Kahlert CR, Kohler P. SARS-CoV-2 immunity and reasons for non-vaccination among healthcare workers from eastern and northern Switzerland: results from a nested multicentre cross-sectional study Swiss medical weekly 154:3734 2024 [PMID: 38689545]
  11. Kim M, Choi Y, Kim SY, Cho A, Kim H, Chae JH, Kim KJ, Park D, Kwon YS, Kim MJ, Yum MS, Kong JH, Lee YJ, Lim BC. Severe Neurological Manifestation Associated With Coronavirus Disease 2019 in Children During the Omicron Variant-Predominant Period Pediatric neurology 156:17-25 2024 [PMID: 38692086]
  12. Takahashi H, Eguchi J, Watanabe M, Nakayama M, Wada J. Reduced Immunogenicity of COVID-19 Vaccine in Obese Patients with Type 2 Diabetes: A Cross-Sectional Study Acta medica Okayama 78(2):185-191 2024 [PMID: 38688836]
  13. Choi HK, Maity M, Qureshi M, Haider A, Kapadia S, Fuerte S, Antony S, Razzaq W, Akbar A. Multifaceted Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on ST-Elevation Myocardial Infarction (STEMI): A Literature Review of Incidence, Treatment Modalities, and Outcomes Cureus 16(3):e57288 2024 [PMID: 38690470]
  14. Suzuki R. [Mast Cell-Neutrophil Communication Regulates Allergic Diseases] Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 144(5):483-488 2024 [PMID: 38692921]
  15. Kleebaoon A, Mungmunpuntipantip R, Wiwanitkit V. Satisfaction and reasons for participation in a Covid-19 vaccine clinical trial The National medical journal of India 36(3):204-205 2023 [PMID: 38692618]

See more by clicking HERE


Click HERE to see the publications in the last month.